Structure-forward targeting of claudins with synthetic binders

Alex J Vecchio1

  • 1Department of Structural Biology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York, USA.

FEBS Letters
|August 6, 2026
PubMed
Summary

Developing targeted therapies for claudins, proteins regulating cell transport, is challenging. Understanding claudin assembly and structure is crucial for designing effective biologic and small molecule binders for tight junction therapies.